NAMPT and endothelial dysfunction: Our present data indicate that endothelial dysfunction is mediated by TLR4 activation, since the drug CLI 095, which specifically inhibits TLR4-mediated signalling, prevented the defective relaxations induced by visfatin/eNampt.